WOBURN, MA / ACCESSWIRE / November 1, 2024 / Biofrontera Inc. (Nasdaq:BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of PDT, announces it will report financial results for the three and nine months ended September 30, 2024 on Wednesday, November 13, 2024. The results will be released after the market close on Wednesday, Nov 13 and the company will host a conference call on Thursday, November 14 at 10:00am Eastern Time.
Conference Call and Webcast Information
|
Event: |
Biofrontera Inc. Third Quarter 2024 Financial Results and Business Update Conference Call |
|
Date: |
Thursday, November 14, 2024 |
|
Time: |
10:00am ET |
|
Conference Call: |
1-877-877-1275 (U.S.) 1-412-858-5202 (international) |
|
Webcast: |
Webcast | Third Quarter 2024 Financial Results and Business Update Conference Call |
About Biofrontera Inc.
Biofrontera is a U.S.-based biopharmaceutical company specializing in the treatment of dermatological conditions with a focus on PDT. The Company commercializes the drug-device combination Ameluz® with the RhodoLED® lamp series for PDT of Actinic Keratosis, pre-cancerous skin lesions which may progress to invasive skin cancers1. The Company performs clinical trials to extend the use of the products to treat non-melanoma skin cancers and moderate to severe acne. For more information, visit www.biofrontera-us.com and follow Biofrontera on LinkedIn and X.
1 – https://www.skincancer.org/skin-cancer-information/actinic-keratosis/
Contacts:
Investor Relations
Andrew Barwicki
1-516-662-9461
ir@bfri.com
SOURCE: Biofrontera Inc.
View the original press release on accesswire.com
The clinical data intelligence platform continues executive team expansion following $15 million funding round PALO…
BANGALORE, India, May 23, 2025 /PRNewswire/ -- Quantum Sensors Market is Segmented by Type (Atomic…
This new platform offers an opportunity to share expert insights, common experiences, and inspirations as…
Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 23,…
DUBLIN, May 23, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of…
Ninon Lizé Masclef awarded $100,000 fellowship to turn brain-wave data into 3D visualizations of dreams GREENWICH,…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
